| 837442 |
Brazil |
PROGRAMA NACIONAL DE CONTROLE DE QUALIDADE
PROGRAMA NACIONAL DE CONTROLE DE QUALIDADE
|
COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA
[COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA]
COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA
[COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA]
|
2022-05-30 |
|
|
| PT name |
(COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA) |
| Scheme name in national language |
(COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA) |
|
| 1138638 |
Canada |
CMPT - Canadian Microbiology Proficiency Testing
CMPT - Canadian Microbiology Proficiency Testing
|
COVID-19
COVID-19
|
2024-01-23 |
|
|
| PT name |
(COVID-19) |
| Tested property |
(SARS CoV-2) |
|
| 699949 |
United Kingdom |
UK NEQAS for Immunology, Immunochemistry & Allergy
UK NEQAS for Immunology, Immunochemistry & Allergy
|
UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies
UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies
|
2023-05-30 |
|
|
| PT name |
(UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies) |
| Tested property |
(SARS-CoV-2 / COVID-19 Antibodies) |
|
| 690909 |
Argentina |
ILT - Interlaboratory Test S.A.
ILT - Interlaboratory Test S.A.
|
ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)
ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)
|
2020-06-09 |
|
|
| PT name |
(ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)) |
| Tested property |
(Requirements, testing, marking for COVID-19) |
|
| 794057 |
Australia |
RCPAQAP
RCPAQAP
|
PHLN: SARS-CoV-2 and other coronaviruses
PHLN: SARS-CoV-2 and other coronaviruses
|
2020-10-23 |
|
|
| PT name |
(PHLN: SARS-CoV-2 and other coronaviruses) |
| Remarks |
(Department of Health funded COVID-19 program. Three rounds of this module were offered in 2020 in) (response to the COVID-19 pandemic with plans for another in 2021. This module is suitable for all) (laboratory testing platforms that are utilised in the whole genome sequencing of SARS-CoV-2.
Available) (free of charge to Australian public health laboratories that require the capability to test for SARS-CoV-2.) |
| Tested property |
(Diluted SARS-CoV-2 (inactivated)) (Diluted SARS-CoV-2 (inactivated)) |
|
| 769005 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
SARS-CoV-2 Proficiency Testing Scheme
SARS-CoV-2 Proficiency Testing Scheme
|
2022-05-04 |
|
|
| PT name |
(SARS-CoV-2 Proficiency Testing Scheme) |
| Test item |
(SARS-CoV-2 (Serological)- 3 x 0.75 ml samples for detection for the SARS-CoV-2 antibodies -NEW 2020) (SARS-CoV-2 (Molecular)- 2 x 1.5ml samples for SARS-CoV-2 virus -NEW 2020) (SARS-CoV-2 antigen - 3 x swab based samples (A, B, and C). Non-infectious simulated patient) (nasopharyngeal samples containing the SARS-CoV-2 nucleocapsid protein.) (SARS-CoV-2 (Molecular)- 2 x swab based samples. Non-infectious simulated nasopharyngeal samples) |
| Tested property |
(SARS-CoV-2 IgA, IgG, IgM, Total antibodies) (SARS-CoV-2 virus) (SARS-CoV-2 virus) (SARS-CoV-2 virus - The samples contain the whole genome) (SARS-CoV-2 virus - The samples contain the whole genome) |
| Testing method |
(The samples are derived from naturally occurring material collected via apheresis from patients that have recovered from COVID-19.) |
|
| 690914 |
Argentina |
ILT - Interlaboratory Test S.A.
ILT - Interlaboratory Test S.A.
|
Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112
Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112
|
2020-09-16 |
|
|
| PT name |
(Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112) |
|
| 790376 |
Australia |
RCPAQAP
RCPAQAP
|
PoCT: COVID-19 serology (IgG/IgM)
PoCT: COVID-19 serology (IgG/IgM)
|
2020-10-26 |
|
|
| PT name |
(PoCT: COVID-19 serology (IgG/IgM)) |
| Tested property |
(COVID-19 Serology) |
|
| 1050992 |
France |
CTCB
CTCB
|
RNA SARS-CoV2 (virology)
[ARN SARS-CoV2 (virologie)]
RNA SARS-CoV2 (virology)
[ARN SARS-CoV2 (virologie)]
|
2023-05-24 |
|
|
| PT name |
(RNA SARS-CoV2 (virology)) |
| Scheme name in national language |
(ARN SARS-CoV2 (virologie)) |
| Test item |
(Detection of SARS-CoV2 RNA) |
| Tested property |
(ARN SARS-CoV2 - cell culture supernatant) |
|
| 1271523 |
Hungary |
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
|
POCT: SARS-CoV-2
[POCT: SARS-CoV-2]
POCT: SARS-CoV-2
[POCT: SARS-CoV-2]
|
2024-10-08 |
|
|
| PT name |
(POCT: SARS-CoV-2) |
| Remarks |
(The content of the scheme: SARS-CoV-2 antibody (IgG, IgM, total antibody) and antigen determination) |
| Scheme name in national language |
(POCT: SARS-CoV-2) |
| Tested property |
(Anti-SARS-CoV-2 total qualitative) (Anti-SARS-CoV-2 - IgG qualitative) (Anti-SARS-CoV-2 - IgM qualitative) (SARS-CoV-2 Antigen qualitative) (SARS-CoV-2 interpretation) |
|
| 1129430 |
Spain |
ielab
ielab
|
SARS-CoV-2
[SARS-CoV-2]
SARS-CoV-2
[SARS-CoV-2]
|
2023-11-29 |
|
|
| PT name |
(SARS-CoV-2) |
| Scheme name in national language |
(SARS-CoV-2) |
| Tested property |
(SARS-CoV-2) |
|
| 824901 |
Germany |
Reference Institute for Bioanalytics
Reference Institute for Bioanalytics
|
SARS-CoV-2 Immunology
[SARS-CoV-2 Immunologie]
SARS-CoV-2 Immunology
[SARS-CoV-2 Immunologie]
|
2021-02-16 |
|
|
| PT name |
(SARS-CoV-2 Immunology) |
| Scheme name in national language |
(SARS-CoV-2 Immunologie) |
| Tested property |
(Anti-SARS-CoV-2 IgG, Anti-SARS-CoV-2 IgA) |
|
| 706310 |
Portugal |
Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ
Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ
|
SARS-CoV-2, molecular detection
[SARS-CoV-2, molecular detection]
SARS-CoV-2, molecular detection
[SARS-CoV-2, molecular detection]
|
2024-03-13 |
|
|
| PT name |
(SARS-CoV-2, molecular detection) |
| Scheme name in national language |
(SARS-CoV-2, molecular detection) |
| Tested property |
(SARS-CoV-2 virus) |
|
| 1271562 |
Hungary |
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
|
Virus serology: SARS-CoV-2
[Vírus szerológia: SARS-CoV-2]
Virus serology: SARS-CoV-2
[Vírus szerológia: SARS-CoV-2]
|
2024-10-08 |
|
|
| PT name |
(Virus serology: SARS-CoV-2) |
| Remarks |
(The content of the scheme: SARS-CoV-2 antibody (IgG-, IgG-S, IgG-N, IgM, IgA, total antibody) |
| Scheme name in national language |
(Vírus szerológia: SARS-CoV-2) |
| Tested property |
(Anti-SARS-CoV-2 total (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG-S (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG-N (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgM (OD, S/CO, quantitative, evaluation)) |
|
| 907768 |
Germany |
Institut für Qualitätssicherung Lübeck (IfQ-Lübeck)
Institut für Qualitätssicherung Lübeck (IfQ-Lübeck)
|
Antibodies against SARS-CoV-2
[Antikörper gegen SARS-CoV-2]
Antibodies against SARS-CoV-2
[Antikörper gegen SARS-CoV-2]
|
2021-11-25 |
|
|
| PT name |
(Antibodies against SARS-CoV-2) |
| Scheme name in national language |
(Antikörper gegen SARS-CoV-2) |
| Tested property |
(Anti-SARS-CoV-2 (NCP) IgG) (Anti-SARS-CoV-2 (S1) IgG) |
|
| 925094 |
United Kingdom |
UK NEQAS for Microbiology
UK NEQAS for Microbiology
|
Molecular detection of SARS-CoV-2
[Molecular detection of SARS-CoV-2]
Molecular detection of SARS-CoV-2
[Molecular detection of SARS-CoV-2]
|
2022-05-13 |
|
|
| PT name |
(Molecular detection of SARS-CoV-2) |
| Scheme name in national language |
(Molecular detection of SARS-CoV-2) |
| Test item |
(/ absence of SARS-CoV-2 nucleic acid by molecular methods, genotyping of SARS-CoV-2 (if performed)) |
| Tested property |
(SARS-CoV-2 nucleic acid) |
|
| 789737 |
Australia |
RCPAQAP
RCPAQAP
|
Molecular Coronavirus SARS-CoV-2
Molecular Coronavirus SARS-CoV-2
|
2020-10-28 |
|
|
| PT name |
(Molecular Coronavirus SARS-CoV-2) |
| Tested property |
(Coronavirus SARS-CoV2) |
|
| 790103 |
Australia |
RCPAQAP
RCPAQAP
|
Coronavirus SARS CoV-2 Antibodies
Coronavirus SARS CoV-2 Antibodies
|
2020-10-27 |
|
|
| PT name |
(Coronavirus SARS CoV-2 Antibodies) |
| Tested property |
(SARS CoV-2) |
|
| 1160040 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Antigen Detection – SARS-CoV-2 (Ag) (410)
[Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)]
Virus Antigen Detection – SARS-CoV-2 (Ag) (410)
[Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)]
|
2024-04-16 |
|
|
| PT name |
(Virus Antigen Detection – SARS-CoV-2 (Ag) (410)) |
| Remarks |
(samples with antigen from SARS-CoV-2 (inactivated) and, if necessary, samples with antigen from human) (immunoassays for the detection of SARS-CoV-2 antigen.
The interdisciplinary, non-profit) |
| Scheme name in national language |
(Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)) |
| Tested property |
(SARS-CoV-2 antigen) |
|
| 705752 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - TLR Coronavírus (SARS-CoV2): antigen
[EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno]
Clinical PT - TLR Coronavírus (SARS-CoV2): antigen
[EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno]
|
2020-09-10 |
|
|
| PT name |
(Clinical PT - TLR Coronavírus (SARS-CoV2): antigen) |
| Scheme name in national language |
(EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno) |
| Tested property |
(Coronavírus (SARS-CoV2)) |
|
